According to Aspen Pharmacare's latest financial reports the company's current revenue (TTM) is $2.17 B. In 2023 the company made a revenue of $2.17 B a decrease over the years 2022 revenue that were of $2.38 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | $2.17 B | -8.84% |
2022 | $2.38 B | -9.55% |
2021 | $2.63 B | 34.71% |
2020 | $1.95 B | -22.55% |
2019 | $2.52 B | -9.69% |
2018 | $2.79 B | -11.93% |
2017 | $3.17 B | 31.68% |
2016 | $2.41 B | -18.21% |
2015 | $2.94 B | 5.71% |
2014 | $2.78 B | 42.76% |
2013 | $1.95 B | 4.29% |
2012 | $1.87 B | 2.48% |
2011 | $1.82 B | 45.63% |
2010 | $1.25 B | 14.69% |
2009 | $1.09 B | 82.91% |
2008 | $0.59 B | 3.22% |
2007 | $0.57 B | 19.48% |
2006 | $0.48 B | 14.61% |
2005 | $0.42 B | 17.65% |
2004 | $0.35 B | 19.99% |
2003 | $0.29 B |